Recent News for ANAB - AnaptysBio, Inc.

Date Title
Mar 12 Introducing AnaptysBio (NASDAQ:ANAB), The Stock That Dropped 42% In The Last Year
Mar 6 All You Need to Know About AnaptysBio, Inc. (ANAB) Rating Upgrade to Buy
Mar 4 AnaptysBio to Present at the Cowen and Company 39th Annual Health Care Conference
Feb 28 AnaptysBio beats by $0.27
Feb 28 AnaptysBio Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Pipeline Updates
Jan 14 Why Biotech Investors Should Look At AnaptysBio
Jan 2 AnaptysBio to Present at J.P. Morgan 37th Annual Healthcare Conference
Dec 21 The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Dec 20 H.C. Wainwright debuts new biotech buy list
Dec 20 Benzinga's Top Upgrades, Downgrades For December 20, 2018
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Dec 19 The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Dec 13 Hedge Funds Are Crazy About AnaptysBio, Inc. (ANAB)
Dec 4 Wedbush Moves To The Sidelines On Tesaro Following Glaxo Deal
Nov 26 Research Report Identifies Ebix, Gold Resource, Mastech Digital, AmeriGas Partners, Tactile Systems Technology, and AnaptysBio with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Nov 21 Benzinga's Top Upgrades, Downgrades For November 21, 2018
Nov 19 Aimmune up 6% premarket on publication of successful late-stage study of peanut allergy candidate AR101
Nov 15 The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results
Nov 9 Here's Why AnaptysBio, Inc. Slipped on Friday
Nov 9 Short Seller's Case on AnaptysBio: Bad Data and CEO Resume Snafu
Nov 9 AnaptysBio Inc. Sets Up More Shots on Goal in the Third Quarter
Nov 8 AnaptysBio beats by $0.06, misses on revenue
Nov 8 AnaptysBio Announces Third Quarter 2018 Financial Results and Provides Pipeline Updates
Nov 5 AnaptysBio to Participate in Upcoming Investor Conferences
Oct 11 Here's Why AnaptysBio Rose 12.6% in September

Back to the Main ANAB Page...